Urinary Bladder, Overactive
"Urinary Bladder, Overactive" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Symptom of overactive detrusor muscle of the URINARY BLADDER that contracts with abnormally high frequency and urgency. Overactive bladder is characterized by the frequent feeling of needing to urinate during the day, during the night, or both. URINARY INCONTINENCE may or may not be present.
| Descriptor ID |
D053201
|
| MeSH Number(s) |
C12.777.829.866 C13.351.968.829.813 C23.888.942.343.780
|
| Concept/Terms |
Overactive Detrusor- Overactive Detrusor
- Detrusor, Overactive
- Overactive Detrusor Function
- Detrusor Function, Overactive
|
Below are MeSH descriptors whose meaning is more general than "Urinary Bladder, Overactive".
Below are MeSH descriptors whose meaning is more specific than "Urinary Bladder, Overactive".
This graph shows the total number of publications written about "Urinary Bladder, Overactive" by people in this website by year, and whether "Urinary Bladder, Overactive" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 |
| 2007 | 3 | 0 | 3 |
| 2008 | 7 | 0 | 7 |
| 2009 | 6 | 0 | 6 |
| 2010 | 11 | 3 | 14 |
| 2011 | 6 | 2 | 8 |
| 2012 | 10 | 0 | 10 |
| 2013 | 13 | 0 | 13 |
| 2014 | 14 | 2 | 16 |
| 2015 | 6 | 0 | 6 |
| 2016 | 8 | 2 | 10 |
| 2017 | 8 | 3 | 11 |
| 2018 | 11 | 1 | 12 |
| 2019 | 9 | 1 | 10 |
| 2020 | 6 | 1 | 7 |
| 2021 | 11 | 1 | 12 |
| 2022 | 12 | 0 | 12 |
| 2023 | 13 | 0 | 13 |
| 2024 | 9 | 1 | 10 |
Below are the most recent publications written about "Urinary Bladder, Overactive" by people in Profiles.
-
A Multicenter Prospective Cohort Study of Antibiotics for OnabotulinumtoxinA. Urogynecology (Phila). 2025 Mar 01; 31(3):258-265.
-
Frailty, Specialized Care, and Sociodemographic Factors: Disparities in Oral Pharmacotherapy Class Utilization Among Medicare Part D Beneficiaries With Overactive Bladder in the United States. Urology. 2024 Sep; 191:49-56.
-
The AUA/SUFU guideline on the diagnosis and treatment of idiopathic overactive bladder. Neurourol Urodyn. 2024 Nov; 43(8):1742-1752.
-
Efficacy and safety of onabotulinumtoxinA for the treatment of overactive bladder in men and women: A pooled analysis. Neurourol Urodyn. 2024 Nov; 43(8):1765-1775.
-
Microbiologist in the Clinic: Postmenopausal Woman with Chronic OAB and Positive Urine Culture. Int Urogynecol J. 2024 Aug; 35(8):1581-1584.
-
The AUA/SUFU Guideline on the Diagnosis and Treatment of Idiopathic Overactive Bladder. J Urol. 2024 Jul; 212(1):11-20.
-
A prospective study to assess the effectiveness and safety of the BlueWind System in the treatment of patients diagnosed with urgency urinary incontinence. Neurourol Urodyn. 2024 Sep; 43(7):1491-1503.
-
Sacral neuromodulation in nursing home residents: Predictors of success and complications in a national cohort of older adults. Neurourol Urodyn. 2024 Sep; 43(7):1534-1544.
-
Fragility of overactive bladder medication clinical trials: A systematic review. Neurourol Urodyn. 2024 Sep; 43(7):1523-1533.
-
Variation in Defining Retention After Onabotulinum Toxin A for Overactive Bladder: A Systematic Review. Urogynecology (Phila). 2024 Sep 01; 30(9):736-741.